Results for
"[search-keyword]"
Sponsor content
94 result(s) found, displaying 41 to 50
-
Prescription medicine registrationActive ingredients: sofosbuvir; velpatasvir.
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Prescription medicine registrationActive ingredients: emtricitabine; tenofovir alafenamide fumarate.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Remdesivir
-
Prescription medicine decision summaryTGA decision: Veklury (remdesivir) is provisionally approved to treat Coronavirus Disease 2019 (COVID-19) in adults and adolescents
-
Prescription medicine registrationActive ingredients: remdesivir.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle.